BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30029202)

  • 1. Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid.
    Beauvais D; Goossens JF; Boyle E; Allal B; Lafont T; Chatelut E; Herbaux C; Morschhauser F; Genay S; Odou P; Danel C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():158-166. PubMed ID: 30029202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
    Veeraraghavan S; Viswanadha S; Thappali S; Govindarajulu B; Vakkalanka S; Rangasamy M
    J Pharm Biomed Anal; 2015 Mar; 107():151-8. PubMed ID: 25594893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid and sensitive method for quantification of ibrutinib in rat plasma by UPLC-ESI-MS/MS: validation and application to pharmacokinetic studies of a novel ibrutinib nanocrystalline.
    Sun S; Cheng D; Kong S; Li X; Li T; Yu Q; Wang L
    Biomed Chromatogr; 2020 Jan; 34(1):e4703. PubMed ID: 31629393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.
    Sun LN; Zhao Y; Qian ZY; Chen XL; Ma H; Guo YJ; Shen H; Wang YQ
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies.
    Rood JJM; van Hoppe S; Schinkel AH; Schellens JHM; Beijnen JH; Sparidans RW
    J Pharm Biomed Anal; 2016 Jan; 118():123-131. PubMed ID: 26540627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput salting-out assisted liquid-liquid extraction using a 3D printed device and its application in the quantification of ibrutinib and its metabolite PCI-45227 in human serum.
    Écsiová D; Šimkovič M; Uher M; Hroch M
    J Pharm Biomed Anal; 2022 Sep; 219():114923. PubMed ID: 35830774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS.
    Qiu X; Lin Q; Ning Z; Qian X; Li P; Ye L; Xie S
    J Pharm Biomed Anal; 2019 Mar; 166():66-70. PubMed ID: 30612075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of evobrutinib and its metabolite evobrutinib-diol in dog plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry.
    Yang J; Yu H; Tang Q
    Biomed Chromatogr; 2019 Sep; 33(9):e4575. PubMed ID: 31069837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioanalysis of ibrutinib, and its dihydrodiol- and glutathione cycle metabolites by liquid chromatography-tandem mass spectrometry.
    Rood JJM; Dormans PJA; van Haren MJ; Schellens JHM; Beijnen JH; Sparidans RW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():14-21. PubMed ID: 29778873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of naringenin on the pharmacokinetics of ibrutinib in rat: A drug-drug interaction study.
    Liu J; Liu H; Zeng Q
    Biomed Chromatogr; 2019 May; 33(5):e4507. PubMed ID: 30754071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous measurement of acalabrutinib, ibrutinib, and their metabolites in beagle dog plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Jiang Z; Shi L; Zhang Y; Lin G; Wang Y
    J Pharm Biomed Anal; 2020 Nov; 191():113613. PubMed ID: 32971496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
    Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
    J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
    Lin PP; Chen WL; Yuan F; Sheng L; Wu YJ; Zhang WW; Li GQ; Xu HR; Li XN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():82-91. PubMed ID: 29102244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma.
    Hupert M; Elfgen A; Schartmann E; Schemmert S; Buscher B; Kutzsche J; Willbold D; Santiago-Schübel B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():123-129. PubMed ID: 29248770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of zopiclone and zolpidem in whole blood by liquid-liquid extraction and UHPLC-MS/MS.
    Eliassen E; Kristoffersen L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Nov; 971():72-80. PubMed ID: 25264915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple determination of plasma ibrutinib concentration using high-performance liquid chromatography.
    Yasu T; Momo K; Yasui H; Kuroda S
    Biomed Chromatogr; 2019 Mar; 33(3):e4435. PubMed ID: 30421802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of tandospirone and its active metabolite, 1-[2-pyrimidyl]-piperazine in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Hu W; Jia M; He S; Xie H; Jiang X; Wang L
    Biomed Chromatogr; 2019 Jul; 33(7):e4525. PubMed ID: 30822365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring.
    Gradinaru J; Vullioud A; Eap CB; Ansermot N
    J Pharm Biomed Anal; 2014 Jan; 88():36-44. PubMed ID: 24036032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a hydrophilic interaction ultra-high-performance liquid chromatography-tandem mass spectrometry method for rapid simultaneous determination of 19 free amino acids in rat plasma and urine.
    Wen Y; Yuan X; Qin F; Zhao L; Xiong Z
    Biomed Chromatogr; 2019 Jan; 33(1):e4387. PubMed ID: 30238479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of six bioactive constituents of Guizhi Fuling Capsule in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study.
    Zhao L; Xiong Z; Sui Y; Zhu H; Zhou Z; Wang Z; Zhao Y; Xiao W; Lin J; Bi K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():49-57. PubMed ID: 26262597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.